Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $29.32, demonstrating a -3.04% change from the preceding day's closing price. This change lagged the S&P 500's 0.21% gain on the day. Elsewhere, the Dow gained 1.03%, while the tech-heavy Nasdaq lost 0.22%.
The company's stock has dropped by 9.43% in the past month, falling short of the Medical sector's loss of 0.43% and the S&P 500's gain of 1.7%.
The upcoming earnings release of Hims & Hers Health, Inc. will be of great interest to investors. The company's earnings report is expected on August 10, 2026. The company is expected to report EPS of -$0.07, down 141.18% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $690.21 million, indicating a 26.68% increase compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.27 per share and a revenue of $2.91 billion, demonstrating changes of -150.94% and +23.78%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Hims & Hers Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 49.21% lower. Hims & Hers Health, Inc. is holding a Zacks Rank of #3 (Hold) right now.
Looking at valuation, Hims & Hers Health, Inc. is presently trading at a Forward P/E ratio of 1134. This valuation marks a premium compared to its industry average Forward P/E of 24.44.
We can additionally observe that HIMS currently boasts a PEG ratio of 85.1. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical Info Systems was holding an average PEG ratio of 2.9 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 75, putting it in the top 31% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).